Fig. 2From: Successful salvage surgery followed by second ALK–TKI after alectinib failure in a patient with ALK-positive NSCLCComputed tomography showed that the lung tumor had regrown, while the lymph nodes had shrunk after 6 months of the alectinib treatmentBack to article page